Hosp. de Navarra

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Head and neck cancer1 trial
• Lupus (SLE)1 trial
• Multiple myeloma1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Johnson & Johnson Enterprise Innovation Inc.1 trial

Running trials

• Recruiting

  A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma

  NCT07589634· Phase 2· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Multiple myeloma1 recruiting

Closed trials

• Recruiting

  JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC

  NCT04892173· Phase 3· Johnson & Johnson Enterprise Innovation Inc.· Source

• Completed

  A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus

  NCT04882878· Phase 2· Janssen Research & Development, LLC· Source